• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk.癌症家族史、阿什肯纳兹犹太血统与胰腺癌风险。
Br J Cancer. 2019 Apr;120(8):848-854. doi: 10.1038/s41416-019-0426-5. Epub 2019 Mar 14.
2
Prevalence of BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and pancreatic cancer.BRCA1 和 BRCA2 突变在具有乳腺癌和胰腺癌的阿什肯纳兹犹太家族中的流行率。
Cancer. 2012 Jan 15;118(2):493-9. doi: 10.1002/cncr.26191. Epub 2011 May 19.
3
Identification of germline genetic mutations in patients with pancreatic cancer.胰腺癌患者种系基因突变的鉴定。
Cancer. 2015 Dec 15;121(24):4382-8. doi: 10.1002/cncr.29664. Epub 2015 Oct 6.
4
The rate of the recurrent MSH6 mutations in Ashkenazi Jewish breast cancer patients.阿什肯纳兹犹太族乳腺癌患者中MSH6复发性突变的发生率。
Cancer Causes Control. 2019 Jan;30(1):97-101. doi: 10.1007/s10552-018-1106-0. Epub 2018 Nov 30.
5
Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation.与具有强烈家族史但无可识别 BRCA1/2 突变的阿什肯纳兹犹太裔女性乳腺癌风险相关的遗传变异。
Hum Genet. 2013 May;132(5):523-36. doi: 10.1007/s00439-013-1269-4. Epub 2013 Jan 25.
6
The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancer.以色列胃癌和胰腺癌患者中 MSH2 和 MSH6 基因的阿什肯纳兹犹太突变的发现者。
Fam Cancer. 2012 Jun;11(2):243-7. doi: 10.1007/s10689-011-9507-1.
7
Incidence of BRCA1 and BRCA2 non-founder mutations in patients of Ashkenazi Jewish ancestry.阿什肯纳兹犹太裔患者中BRCA1和BRCA2非始祖突变的发生率。
Breast Cancer Res Treat. 2015 Jan;149(1):223-7. doi: 10.1007/s10549-014-3218-x. Epub 2014 Dec 6.
8
Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term outcomes.基于人群的 BRCA 检测在阿什肯纳兹犹太人中的随机试验:长期结果。
BJOG. 2020 Feb;127(3):364-375. doi: 10.1111/1471-0528.15905. Epub 2019 Sep 10.
9
The I1307K APC mutation does not predispose to colorectal cancer in Jewish Ashkenazi breast and breast-ovarian cancer kindreds.I1307K APC突变不会使犹太裔阿什肯纳兹乳腺癌和乳腺-卵巢癌家族易患结直肠癌。
Cancer Res. 1997 Dec 15;57(24):5480-4.
10
Carrier rate of APC I1307K is not increased in inflammatory bowel disease patients of Ashkenazi Jewish origin.在阿什肯纳兹犹太裔炎症性肠病患者中,APC I1307K的携带率并未升高。
Hum Genet. 2001 Mar;108(3):205-10. doi: 10.1007/s004390100474.

引用本文的文献

1
Racial/Ethnic Differences and Effects of Clinical/Socioeconomic Factors on Time from Diagnosis to Treatment in Pancreatic Cancer.种族/民族差异以及临床/社会经济因素对胰腺癌从诊断到治疗的时间的影响
J Gastrointest Cancer. 2025 Feb 15;56(1):67. doi: 10.1007/s12029-025-01188-x.
2
Passive smoking and risk of pancreatic cancer: an updated systematic review and meta-analysis.被动吸烟与胰腺癌风险:一项更新的系统评价和荟萃分析。
PeerJ. 2024 Oct 8;12:e18017. doi: 10.7717/peerj.18017. eCollection 2024.
3
Roles of long non‑coding RNA SNHG16 in human digestive system cancer (Review).长链非编码 RNA SNHG16 在人类消化系统癌症中的作用(综述)。
Oncol Rep. 2024 Aug;52(2). doi: 10.3892/or.2024.8765. Epub 2024 Jun 28.
4
Advancements in Pancreatic Cancer Detection: Integrating Biomarkers, Imaging Technologies, and Machine Learning for Early Diagnosis.胰腺癌检测的进展:整合生物标志物、成像技术和机器学习以实现早期诊断。
Cureus. 2024 Mar 20;16(3):e56583. doi: 10.7759/cureus.56583. eCollection 2024 Mar.
5
Understanding familial risk of pancreatic ductal adenocarcinoma.了解胰腺导管腺癌的家族风险。
Fam Cancer. 2024 Nov;23(4):419-428. doi: 10.1007/s10689-024-00383-2. Epub 2024 Apr 12.
6
Pancreatic Cancer Health Disparity: Pharmacologic Anthropology.胰腺癌的健康差异:药物人类学
Cancers (Basel). 2023 Oct 20;15(20):5070. doi: 10.3390/cancers15205070.
7
Pancreatic Cancer Exposome Profile to Aid Early Detection and Inform Prevention Strategies.胰腺癌暴露组图谱助力早期检测并为预防策略提供信息
J Clin Med. 2021 Apr 13;10(8):1665. doi: 10.3390/jcm10081665.
8
Investigating disparities: the effect of social environment on pancreatic cancer survival in metastatic patients.调查差异:社会环境对转移性胰腺癌患者生存的影响
J Gastrointest Oncol. 2020 Aug;11(4):633-643. doi: 10.21037/jgo-20-39.
9
A pooled genome-wide association study identifies pancreatic cancer susceptibility loci on chromosome 19p12 and 19p13.3 in the full-Jewish population.一项全人群的基因组关联研究在全犹太人群中鉴定出 19 号染色体 19p12 和 19p13.3 上的胰腺癌易感性位点。
Hum Genet. 2021 Feb;140(2):309-319. doi: 10.1007/s00439-020-02205-8. Epub 2020 Jul 15.
10
Early detection of pancreatic cancer.早期胰腺癌检测。
Lancet Gastroenterol Hepatol. 2020 Jul;5(7):698-710. doi: 10.1016/S2468-1253(19)30416-9. Epub 2020 Mar 2.

本文引用的文献

1
The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women.在阿什肯纳兹女性中,BRCA1基因的185delAG和5382insC以及BRCA2基因的6174delT这几种始祖突变出现在60%的卵巢癌患者和30%的早发性乳腺癌患者中。
Am J Hum Genet. 1997 Mar;60(3):505-14.

癌症家族史、阿什肯纳兹犹太血统与胰腺癌风险。

Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk.

机构信息

Department of Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 450 Brookline Avenue, Boston, MA, 02215, USA.

出版信息

Br J Cancer. 2019 Apr;120(8):848-854. doi: 10.1038/s41416-019-0426-5. Epub 2019 Mar 14.

DOI:10.1038/s41416-019-0426-5
PMID:30867564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6474278/
Abstract

BACKGROUND

Individuals with a family history of cancer may be at increased risk of pancreatic cancer. Ashkenazi Jewish (AJ) individuals carry increased risk for pancreatic cancer and other cancer types.

METHODS

We examined the association between family history of cancer, AJ heritage, and incident pancreatic cancer in 49 410 male participants of the prospective Health Professionals Follow-up Study. Hazard ratios (HRs) were estimated using multivariable-adjusted Cox proportional hazards models.

RESULTS

During 1.1 million person-years (1986-2016), 452 participants developed pancreatic cancer. Increased risk of pancreatic cancer was observed in individuals with a family history of pancreatic (HR, 2.79; 95% confidence interval [CI], 1.28-6.07) or breast cancer (HR, 1.40; 95% CI, 1.01-1.94). There was a trend towards higher risk of pancreatic cancer in relation to a family history of colorectal cancer (HR, 1.21; 95% CI, 0.95-1.55) or AJ heritage (HR, 1.29; 95% CI, 0.94-1.77). The risk was highly elevated among AJ men with a family history of breast or colorectal cancer (HR, 2.61 [95% CI, 1.41-4.82] and 1.92 [95% CI, 1.05-3.49], respectively).

CONCLUSION

Family history of pancreatic cancer was associated with increased risk of this malignancy. Family history of breast or colorectal cancer was associated with the increased risk among AJ men.

摘要

背景

有癌症家族史的个体患胰腺癌的风险可能会增加。阿什肯纳兹犹太人(AJ)个体患胰腺癌和其他癌症类型的风险增加。

方法

我们在前瞻性健康专业人员随访研究的 49410 名男性参与者中,研究了癌症家族史、AJ 血统与胰腺癌发病之间的关联。使用多变量调整的 Cox 比例风险模型估计风险比(HR)。

结果

在 110 万人年(1986-2016 年)期间,有 452 名参与者患上了胰腺癌。有胰腺癌家族史(HR,2.79;95%置信区间[CI],1.28-6.07)或乳腺癌家族史(HR,1.40;95%CI,1.01-1.94)的个体患胰腺癌的风险增加。与结直肠癌(HR,1.21;95%CI,0.95-1.55)或 AJ 血统(HR,1.29;95%CI,0.94-1.77)家族史相关,胰腺癌的发病风险呈上升趋势。具有乳腺癌或结直肠癌家族史的 AJ 男性的风险显著升高(HR,2.61[95%CI,1.41-4.82]和 1.92[95%CI,1.05-3.49])。

结论

胰腺癌家族史与这种恶性肿瘤的风险增加相关。乳腺癌或结直肠癌家族史与 AJ 男性的风险增加相关。